°Ë»ö
 

 Anti-tumor Effects of GCP
It is expected that GCP will be useful for cancer treatment and other related diseases due to its anti-angiogenic, apoptosis induction, and immune enhancement respectively.

GCP's Inhibitory Effects on Angiogenesis
Angiogenesis is the growth of new blood vessels from existing microvasculature.
Tumor growth is dependent on the angiogenesis process and requires new vessel growth. Therefore, inhibition of angiogenesis is an important means of controlling tumor growth. Genistein has been widely reported to inhibit angiogenesis.

Induction of Apoptosis in Cancer Cells by GCP
Apoptosis, defined as programmed cell death, plays a very important role in many physiological and pathological conditions such as embryo and organ development, immune responses, tumor development and death. Genistein has been reported to induce apoptosis.

 Enhancement of immune Response by GCP
Polysaccharides have been reported to enhance immune response.
GCP contains a rich content of polysaccharides derived from basidiomycetes, which seem to
be responsible for enhancement of immune response.

 Active Ingredients of GCP
GCP is a novel functional food produced by fermentation of soybean isoflavone extracts
with basidiomycetes mushrooms.
GCP contains a rich content of isoflavone aglycons, especially genistein, as well as a rich content of polysaccharides from basidiomycetes.
 
..........................................................................................................................................................
  100gÀÇ GCP¿¡´Â ´ëµÎ ¾à3kgºÐÀÇ ISO Çöóº»ÀÌ Æ÷ÇԵǾî ÀÖ¾î ±× ´ëºÎºÐÀÌ ´ãÀÚ±Õ°úÀÇ ¹ßÈ¿¿¡ ÀÇÇÑ ¾Æ±×¸®ÄÜ À̶ó°í ÇÑ´Ù.

Èí¼öµÇ±â ½±µµ·Ï È°¼ºÀÌ ³ôÀº ÇüÅ·Πº¯È¯ÀÌ µË´Ï´Ù.
GCP¿¡´Â ¾Æ±×¸®ÄÜÀÇ ÇϳªÀÎ °Ô´Ï½ºÅ×ÀÎÀÌ 100g´ç ¾à6g Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
   
 
........................................................................................................................................................
  ISO Çöóº»Àº ´ëµÎ³ª ´ëµÎ Á¦Ç°ÀÇ ¼ººÐ(À¸)·Î¼­ ´ãÀÚ±ÕÀº Ç¥°í¹ö¼¸À̳ª ¿µÈ¥Àܵð µî ½ÄÇ°À̳ª ¹Î°£¾àÀ¸·Î¼­ ÀÏ»óÀûÀ¸·Î ¼·ÃëµÇ°í ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ ¿À·¡µÈ ½Ä»ýÈ°ÀÇ ÀüÅëÀûÀÎ °æÇèÀ¸·ÎºÎÅÍ, GCP´Â ¾ÈÀü¼ºÀÌ ±×¾î´À Á¦Ç°º¸´Ùµµ ³ô´Ù°í ¸»ÇÒ ¼ö ÀÖ¾î ¾ÈÀü¼º¿¡´Â ¹®Á¦ ¾ø´Ù°í »ý°¢µË´Ï´Ù.

°Ç°­ÇÑ »ç¶÷À» ´ë»óÀ¸·Î ÇÑ ¸ð´ÏÅÍ ½ÃÇè(À¸)·Î¼­ 1°³¿ù°£ GCP¸¦ ¼·ÃëÇØ, Ç÷¾× ¹× ¼Òº¯À» äÃëÇß½À´Ï´Ù. Ç÷û »ýÈ­ÇÐ °Ë»ç, Ç÷¾× Çй®Àû °Ë»ç, ¼Òº¯°Ë»ç µî¿¡ ÀÖ¾î ÀÌ»óÀº ÀüÇô ¹ß°ßµÇÁö ¾Ê¾Ò½À´Ï´Ù. ÇÑÆí GCP¿¡ ´ëÇؼ­´Â ±âÃÊÇй®°ú ÀÓ»óÀÇ ¾ç¸é¿¡¼­ ¼¼°è À¯¼öÀÇ ´ëÇС¤¿¬±¸±â°ü°ú °øµ¿ ¿¬±¸¸¦ ½Ç½ÃÇÏ°í ÀÖ½À´Ï´Ù.

¿ÀŸ°í ´ëÇÐ(´ºÁú·£µå)
ÄÝ·Òºñ¾Æ ´ëÇÐ(¹Ì±¹)
Ķ¸®Æ÷´Ï¾Æ ´ëÇÐ µ¥À̺ñ½º±³(¹Ì±¹)
ȪīÀ̵µ ´ëÇÐ(ÀϺ»)



[»ç¾÷ÀÚÁ¤º¸È®ÀÎ]